Lipoamide
データを補完しています。しばらくしてからページを更新すると最新の内容を表示できます
3206-73-3NC(=O)CCCCC1CCSS1FCCDDURTIIUXBY-UHFFFAOYSA-NLipoamide is a monocarboxylic acid amide resulting from the formal condensation of the carboxy group of lipoic acid with ammonia. It has a role as a mouse metabolite, a Saccharomyces cerevisiae metabolite, an Escherichia coli metabolite and a human metabolite. It is a monocarboxylic acid amide and a member of dithiolanes. It is functionally related to a lipoic acid.
3206-73-3、940-69-2DTXSID2046541CHEMBL1403899CHEBI:17460Yellow solid; [Alfa Aesar MSDS]
Solid
146.29 Ų [M+Na]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]
150.4 Ų [M+Na]+ [CCS Type: DT; Method: single field calibrated with ESI Low Concentration Tuning Mix (Agilent)]
150.5 Ų [M+Na]+ [CCS Type: DT; Method: single field calibrated with Agilent tune mix (Agilent)]
139.3 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]
150.6 Ų [M+Na]+
安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。
Warning
H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]
P264, P270, P301+P317, P330, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 40 reports by companies from 1 notifications to the ECHA C&L Inventory.
使用hepatoprotectant
純化方法DL--Lipoamide is recrystallised from EtOH and has UV with max 331nm in MeOH. [Reed et al. J Biol Chem 232 143 1958, IR: Wagner et al. J Am Chem Soc 78 5079 1956, Beilstein 19/7 V 238.]